Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
March 20, 2023
2022 Year in Review
A look at the most interesting and important stories of the past year
Experts discuss navigating cancer and cancer research during the pandemic
Hutch panelists offer their insights on how COVID-19 has impacted patients as well as their efforts to develop cancer treatments
Philanthropic support catalyzes audacious ideas, bold research
Support from thousands of donors gives researchers the time and resources they need to advance high-risk projects with immense potential
How to boost cancer clinical trial participation
New study suggests loosening strict comorbidity criteria would open trials to thousands of previously exempt patients
How new drugs become available to more patients
Filling in the unknowns on the balance between risk and benefit
New insights into CAR T-cell therapy's potential side effects
Detailed study of cytokine release syndrome and neurologic toxicities could help make emerging cancer immunotherapies safer
Patients treated at cancer centers live longer: study
Finding of survival-rate differences between cancer hubs and community hospitals spurs call to ‘figure out the gaps’
‘Totally meant to be’
Why this Seattle teacher was motivated to serve the Fred Hutch high school intern program
Good News at Fred Hutch
Dr. Peter Nelson principal researcher on prostate cancer 'Dream Team'; Dr. Kathi Malone honored by Komen Puget Sound; Dr. Eric Chow leads study of cardioprotective drug that addresses chemo concerns in children; and Dr. Linda Buck receives honorary doctorate from Harvard
Study finds that microinjection platform enables assessment of multiple cancer drugs directly in tumors, predicts systemic response
Data published in Science Translational Medicine show positive findings using patented new technology with multiple cancer drugs tested in xenografted mouse models and canine patients > Results from first-in-human study in lymphoma patients confirm feasibility for toxicity-sparing assessment of drug efficacy in cancer patients
Immunotherapy offers 'new era' for cancer patients
Dr. Stan Riddell wows Science for Life attendees with overview of one of the most promising areas of medical research
Warming trend: Holiday drive collects cozy clothing for homeless youth
Socks, gloves, hats and more will help those served by Teen Feed, a Seattle nonprofit
Nobel Prize Goes to Seattle Researcher Lee Hartwell
Hartwell, president and director of the Fred Hutchinson Cancer Research Center and professor of genetics and medicine at the University of Washington, receives the prestigious honor for his work in yeast genetics